Investment in Cyclo Therapeutics, LLC. (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Dec. 23, 2024 |
Apr. 30, 2025 |
Apr. 30, 2026 |
Apr. 30, 2025 |
|
| Investment in Cyclo Therapeutics, LLC. [Line Items] | ||||
| Outstanding principal and accrued interest | $ 2.5 | |||
| Investment in Cyclo Therapeutics, Inc. [Member] | ||||
| Investment in Cyclo Therapeutics, LLC. [Line Items] | ||||
| Unrealized loss | $ 1.4 | $ 5.1 | ||
| Rafael Holdings Inc [Member] | ||||
| Investment in Cyclo Therapeutics, LLC. [Line Items] | ||||
| Ownership shares increased | 12,998,194 | 12,998,194 | ||
| Rafael Holdings Inc [Member] | Investment in Cyclo Therapeutics, Inc. [Member] | ||||
| Investment in Cyclo Therapeutics, LLC. [Line Items] | ||||
| Ownership percentage | 39.50% | |||
| Cyclo Common Stock [Member] | ||||
| Investment in Cyclo Therapeutics, LLC. [Line Items] | ||||
| Cyclo common stock | 3,968,254 | |||
| X | ||||||||||
- Definition Outstanding principal and accrued interest. No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized loss in equity investments. No definition available.
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|